Shares in Luminex dropped 9 percent for the five-day trading period ended Tuesday. The firm’s shares have declined 13 percent since closing at $14.35 on May 2, the day it released its first-quarter results, which included a 28 percent gain in revenues but a 75 percent drop in profit year over year. Luminex led the 10 stocks that lost value during the trading period.
Bruker BioSciences reversed a two-week skid in its share price and closed up 8 percent for the week.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The New York Times profiles 23andMe's Anne Wojcicki and describes how she bounced back from a bad year.

Fotis Kafatos, the founding president of the European Research Council, has died, according to the Associated Press.

In PLOS this week: genomic analysis of honeybee disease, microRNA profiles of people with lupus nephritis, and more.

The Verge's Angela Chen tried out a gene test for fitness advice, but didn't learn much new information.